Look for any podcast host, guest or anyone
Showing episodes and shows of

Rabbi Emeritus Richard Birnholz

Shows

Congregation Schaarai ZedekCongregation Schaarai ZedekShabbat Service Honoring Rabbi BirnholzJune 6, 2021, marked a milestone in the life of our beloved Rabbi Emeritus Richard Birnholz as he celebrated 50 years in the rabbinate. During Shabbat worship, we honored Rabbi Birnholz and celebrated 50 years of his rabbinate.2021-06-1024 minAt The Same TimeAt The Same TimeYou Have To Put One Foot In Front of the OtherIn part 2 of this 2-part episode, we continue our conversation with Rabbi Joel Simon, Rabbi Michael Weiss, Rabbi Richard Birnholz, and Cantor Deborah Cannizzaro. We talk about how to make sense of what we are all going through with the pandemic, how to show ourselves and others empathy, and the importance of never giving up. Congregation Schaarai Zedek: https://www.zedek.org/ Music: https://www.purple-planet.comSpecial Guests: Cantor Deborrah Cannizzaro, Rabbi Emeritus Richard Birnholz, Rabbi Joel Simon, and Rabbi Michael Weiss.2020-09-2935 minAt The Same TimeAt The Same TimeSometimes Not Having Answers is More Important Than Having ThemIn part 1 of this 2-part episode, we speak with Rabbi Joel Simon, Rabbi Michael Weiss, Cantor Deborah Cannizzaro, and Rabbi Richard Birnholz. We learn more about each of them and how God, spirituality, and connectedness pervade all parts of life - even during a challenging time like a pandemic. Congregation Schaarai Zedek: https://www.zedek.org/ Music: https://www.purple-planet.comSpecial Guests: Cantor Deborrah Cannizzaro, Rabbi Emeritus Richard Birnholz, Rabbi Joel Simon, and Rabbi Michael Weiss.2020-09-1843 minThe Bible Project 2020The Bible Project 2020Episode 33 // Jeremiah from a Jewish Perspective // Rabbi Richard BirnholzToday's episode features a conversation with Rabbi Richard Birnholz, Rabbi Emeritus at Congregation Schaarai Zedek in Tampa, FL. Rabbi Birnholz joined us back in February on Episode 7 for a discussion of Numbers and Deuteronomy.On this episode, Rabbi Birnholz, Celia Ferman, and Mat Hotho discuss the book of Jeremiah and how the lessons of Jeremiah inform ancient and modern Jewish communities. Rabbi Birnholz suggests that Jeremiah’s political shrewdness preserved the Jewish people and provided a model for modern day Jewish communities living in the Diaspora.   Learn more about The Bible Project 2020. Join our...2020-07-2025 minThe Bible Project 2020The Bible Project 2020Episode 7 // Numbers 26 – Deuteronomy 20 // Rabbi Richard BirnholzThis week, we are joined by Rabbi Richard Birnholz, Rabbi Emeritus of Tampa Schaarai Zedek in Tampa, FL. Rabbi Birnholz and Celia Ferman discuss the story of Zelophehad’s daughters in Number 27 as well as the transition from a priestly system to a...2020-02-1023 minThe Bible Project 2020The Bible Project 2020Episode 8 // Numbers 26 – Deuteronomy 20 // Rabbi Richard BirnholzThis week, we are joined by Rabbi Richard Birnholz, Rabbi Emeritus of Tampa Schaarai Zedek in Tampa, FL. Rabbi Birnholz and Celia Ferman discuss the story of Zelophehad’s daughters in Number 27 as well as the transition from a priestly system to a rabbinical system in judaism. We wrestle with two big questions: Why do bad things happen to good people and why is God portrayed as wrathful? And finally, we talk about the ways modern Jewish communities have made the Shema a constant part of their modern lives.  Learn more about The Bible Project 2020. Joi...2020-02-1023 minCongregation Schaarai ZedekCongregation Schaarai ZedekFinding Meaning in Difficult TimesA sermon by Rabbi Richard Birnholz at Congregation Schaarai Zedek in Tampa, Florida on December 13, 2019. Follow us @schaaraizedek or visit our website www.zedek.org.2019-12-1614 minCongregation Schaarai ZedekCongregation Schaarai ZedekSchaarai Zedek's 125th Anniversary - Sermon by Rabbi BirnholzA sermon delivered by Rabbi Richard Birnholz at Congregation Schaarai Zedek in Tampa, Florida on October 25, 2019, at the celebration of Schaarai Zedek's 125th anniversary. Follow us @schaaraizedek or visit our website www.zedek.org.2019-10-2918 minCongregation Schaarai ZedekCongregation Schaarai ZedekSermon by Rabbi BirnholzA sermon delivered by Rabbi Richard Birnholz at Congregation Schaarai Zedek in Tampa, Florida on June 14, 2019. Follow us @schaaraizedek or visit our website www.zedek.org.2019-06-2012 minCongregation Schaarai ZedekCongregation Schaarai ZedekYizkorA Yizkor sermon delivered by Rabbi Richard Birnholz at Congregation Schaarai Zedek in Tampa, Florida on September 19, 2018. Follow us @schaaraizedek or visit our website www.zedek.org.2018-09-2123 minCongregation Schaarai ZedekCongregation Schaarai ZedekJune 29, 2018 Sermon - Rabbi Richard J. BirnholzRabbi Richard J. Birnholz will speak on “The Most Important Piece of Advice I Can Give After 47 Years in the Rabbinate" in his last sermon as Senior Rabbi at Congregation Schaarai Zedek.2018-07-0524 minGeneral Medicine and Primary CareGeneral Medicine and Primary CareHow Small Practices Can Comply with MIPS Quality Reporting Requirements Host: Matt Birnholz, MD Guest: Richard Deem With the advent of the Medicare Quality Payment Program, there are notable practice changes for clinicians. What do these changes mean for you and your practice? To examine the issues and opportunities, host Dr. Matt Birnholz welcomes Richard Deem who is the Senior Vice President of Advocacy at AMA. Mr. Deem will explain how these changes affect small practices in particular, and what physicians in these practices need to know in order to succeed. 2018-02-0200 minInside Medicare\'s New Payment SystemInside Medicare's New Payment SystemHow Small Practices Can Comply with MIPS Quality Reporting RequirementsHost: Matt Birnholz, MD Guest: Richard Deem With the advent of the Medicare Quality Payment Program, there are notable practice changes for clinicians. What do these changes mean for you and your practice? To examine the issues and opportunities, host Dr. Matt Birnholz welcomes Richard Deem who is the Senior Vice President of Advocacy at AMA. Mr. Deem will explain how these changes affect small practices in particular, and what physicians in these practices need to know in order to succeed. 2018-02-0200 minPractice ManagementPractice ManagementHow Small Practices Can Comply with MIPS Quality Reporting RequirementsHost: Matt Birnholz, MD Guest: Richard Deem With the advent of the Medicare Quality Payment Program, there are notable practice changes for clinicians. What do these changes mean for you and your practice? To examine the issues and opportunities, host Dr. Matt Birnholz welcomes Richard Deem who is the Senior Vice President of Advocacy at AMA. Mr. Deem will explain how these changes affect small practices in particular, and what physicians in these practices need to know in order to succeed. 2018-02-0200 minHealthcare PolicyHealthcare PolicyHow Small Practices Can Comply with MIPS Quality Reporting Requirements Host: Matt Birnholz, MD Guest: Richard Deem With the advent of the Medicare Quality Payment Program, there are notable practice changes for clinicians. What do these changes mean for you and your practice? To examine the issues and opportunities, host Dr. Matt Birnholz welcomes Richard Deem who is the Senior Vice President of Advocacy at AMA. Mr. Deem will explain how these changes affect small practices in particular, and what physicians in these practices need to know in order to succeed. 2018-02-0200 minPerspectives with the AMAPerspectives with the AMAHow Small Practices Can Comply with MIPS Quality Reporting Requirements Host: Matt Birnholz, MD Guest: Richard Deem With the advent of the Medicare Quality Payment Program, there are notable practice changes for clinicians. What do these changes mean for you and your practice? To examine the issues and opportunities, host Dr. Matt Birnholz welcomes Richard Deem who is the Senior Vice President of Advocacy at AMA. Mr. Deem will explain how these changes affect small practices in particular, and what physicians in these practices need to know in order to succeed. 2018-02-0200 minGrand Rounds NationGrand Rounds NationAlternative Approaches to the Treatment of Depression, Part 2Host: Matt Birnholz, MD This session of Grand Rounds Nation is provided by the American College of Osteopathic Family Physicians (ACOFP), and features Dr. Richard Cottrell speaking on both first line and alternative approaches to the treatment of depression. Comparisons of antidepressive medications, counseling therapy models, and lifestyle modifications are explored. Additionally, novel treatment strategies in current use or on the horizon such as bright light therapy, transcranial magnetic stimulation, electroconvulsive therapy, and deep brain stimulation are investigated. This is Part 2 of a lecture in two parts. Part 1 >>2012-10-2600 minPsychiatry and Mental HealthPsychiatry and Mental HealthAlternative Approaches to the Treatment of Depression, Part 2 Host: Matt Birnholz, MD This session of Grand Rounds Nation is provided by the American College of Osteopathic Family Physicians (ACOFP), and features Dr. Richard Cottrell speaking on both first line and alternative approaches to the treatment of depression. Comparisons of antidepressive medications, counseling therapy models, and lifestyle modifications are explored. Additionally, novel treatment strategies in current use or on the horizon such as bright light therapy, transcranial magnetic stimulation, electroconvulsive therapy, and deep brain stimulation are investigated. This is Part 2 of a lecture in two parts. Part 1 >>2012-10-2600 minPsychiatry and Mental HealthPsychiatry and Mental HealthAlternative Approaches to the Treatment of Depression, Part 2 Host: Matt Birnholz, MD This session of Grand Rounds Nation is provided by the American College of Osteopathic Family Physicians (ACOFP), and features Dr. Richard Cottrell speaking on both first line and alternative approaches to the treatment of depression. Comparisons of antidepressive medications, counseling therapy models, and lifestyle modifications are explored. Additionally, novel treatment strategies in current use or on the horizon such as bright light therapy, transcranial magnetic stimulation, electroconvulsive therapy, and deep brain stimulation are investigated. This is Part 2 of a lecture in two parts. Part 1 >>2012-10-2600 minPsychiatry and Mental HealthPsychiatry and Mental HealthAlternative Approaches to the Treatment of Depression, Part 1 Host: Matt Birnholz, MD This session of Grand Rounds Nation is provided by the American College of Osteopathic Family Physicians (ACOFP), and features Dr. Richard Cottrell speaking on both first line and alternative approaches to the treatment of depression. Comparisons of antidepressive medications, counseling therapy models, and lifestyle modifications are explored. Additionally, novel treatment strategies in current use or on the horizon such as bright light therapy, transcranial magnetic stimulation, electroconvulsive therapy, and deep brain stimulation are investigated. This is Part 1 of a lecture in two parts. Part 2 >>2012-10-2600 minGrand Rounds NationGrand Rounds NationAlternative Approaches to the Treatment of Depression, Part 1Host: Matt Birnholz, MD This session of Grand Rounds Nation is provided by the American College of Osteopathic Family Physicians (ACOFP), and features Dr. Richard Cottrell speaking on both first line and alternative approaches to the treatment of depression. Comparisons of antidepressive medications, counseling therapy models, and lifestyle modifications are explored. Additionally, novel treatment strategies in current use or on the horizon such as bright light therapy, transcranial magnetic stimulation, electroconvulsive therapy, and deep brain stimulation are investigated. This is Part 1 of a lecture in two parts. Part 2 >>2012-10-2600 minPsychiatry and Mental HealthPsychiatry and Mental HealthAlternative Approaches to the Treatment of Depression, Part 1 Host: Matt Birnholz, MD This session of Grand Rounds Nation is provided by the American College of Osteopathic Family Physicians (ACOFP), and features Dr. Richard Cottrell speaking on both first line and alternative approaches to the treatment of depression. Comparisons of antidepressive medications, counseling therapy models, and lifestyle modifications are explored. Additionally, novel treatment strategies in current use or on the horizon such as bright light therapy, transcranial magnetic stimulation, electroconvulsive therapy, and deep brain stimulation are investigated. This is Part 1 of a lecture in two parts. Part 2 >>2012-10-2600 minGeriatricsGeriatricsUniversity of Arizona - Preclinical Stage Alzheimer's Disease: Characterizing and Defining the Transition Between Normal and Pathological Cognitive Aging, Part 3 Host: Matt Birnholz, MD For people who carry genetic predispositions toward Alzheimer's Disease, little is currently known about predicting the onset, course, and severity of disease at the individual level. However, because cogntitive degenerative diseases most often follow a gradual course of symptom progression later in life, medical professionals must be aware of the distinct, discoverable changes that occur at the "preclinical" stage, i.e prior to the symptomatic onset of memory loss. In this session of Grand Rounds from the University of Arizona College of Medicine, participants learn about Alzheimer's Disease from an unique perspective...2011-04-1900 minGeneticsGeneticsUniversity of Arizona - Preclinical Stage Alzheimer's Disease: Characterizing and Defining the Transition Between Normal and Pathological Cognitive Aging, Part 3 Host: Matt Birnholz, MD For people who carry genetic predispositions toward Alzheimer's Disease, little is currently known about predicting the onset, course, and severity of disease at the individual level. However, because cogntitive degenerative diseases most often follow a gradual course of symptom progression later in life, medical professionals must be aware of the distinct, discoverable changes that occur at the "preclinical" stage, i.e prior to the symptomatic onset of memory loss. In this session of Grand Rounds from the University of Arizona College of Medicine, participants learn about Alzheimer's Disease from an unique perspective...2011-04-1900 minNeurology and NeurosurgeryNeurology and NeurosurgeryUniversity of Arizona - Preclinical Stage Alzheimer's Disease: Characterizing and Defining the Transition Between Normal and Pathological Cognitive Aging, Part 3 Host: Matt Birnholz, MD For people who carry genetic predispositions toward Alzheimer's Disease, little is currently known about predicting the onset, course, and severity of disease at the individual level. However, because cogntitive degenerative diseases most often follow a gradual course of symptom progression later in life, medical professionals must be aware of the distinct, discoverable changes that occur at the "preclinical" stage, i.e prior to the symptomatic onset of memory loss. In this session of Grand Rounds from the University of Arizona College of Medicine, participants learn about Alzheimer's Disease from an unique perspective...2011-04-1900 minGrand Rounds NationGrand Rounds NationUniversity of Arizona - Preclinical Stage Alzheimer's Disease: Characterizing and Defining the Transition Between Normal and Pathological Cognitive Aging, Part 3Host: Matt Birnholz, MD For people who carry genetic predispositions toward Alzheimer's Disease, little is currently known about predicting the onset, course, and severity of disease at the individual level. However, because cogntitive degenerative diseases most often follow a gradual course of symptom progression later in life, medical professionals must be aware of the distinct, discoverable changes that occur at the "preclinical" stage, i.e prior to the symptomatic onset of memory loss. In this session of Grand Rounds from the University of Arizona College of Medicine, participants learn about Alzheimer's Disease from an unique perspective...2011-04-1900 minNeurology and NeurosurgeryNeurology and NeurosurgeryUniversity of Arizona - Preclinical Stage Alzheimer's Disease: Characterizing and Defining the Transition Between Normal and Pathological Cognitive Aging, Part 3 Host: Matt Birnholz, MD For people who carry genetic predispositions toward Alzheimer's Disease, little is currently known about predicting the onset, course, and severity of disease at the individual level. However, because cogntitive degenerative diseases most often follow a gradual course of symptom progression later in life, medical professionals must be aware of the distinct, discoverable changes that occur at the "preclinical" stage, i.e prior to the symptomatic onset of memory loss. In this session of Grand Rounds from the University of Arizona College of Medicine, participants learn about Alzheimer's Disease from an unique perspective...2011-04-1900 minGeriatricsGeriatricsUniversity of Arizona - Preclinical Stage Alzheimer's Disease: Characterizing and Defining the Transition Between Normal and Pathological Cognitive Aging, Part 3 Host: Matt Birnholz, MD For people who carry genetic predispositions toward Alzheimer's Disease, little is currently known about predicting the onset, course, and severity of disease at the individual level. However, because cogntitive degenerative diseases most often follow a gradual course of symptom progression later in life, medical professionals must be aware of the distinct, discoverable changes that occur at the "preclinical" stage, i.e prior to the symptomatic onset of memory loss. In this session of Grand Rounds from the University of Arizona College of Medicine, participants learn about Alzheimer's Disease from an unique perspective...2011-04-1900 minGeneticsGeneticsUniversity of Arizona - Preclinical Stage Alzheimer's Disease: Characterizing and Defining the Transition Between Normal and Pathological Cognitive Aging, Part 2 Host: Matt Birnholz, MD For people who carry genetic predispositions toward Alzheimer's Disease, little is currently known about predicting the onset, course, and severity of disease at the individual level. However, because cogntitive degenerative diseases most often follow a gradual course of symptom progression later in life, medical professionals must be aware of the distinct, discoverable changes that occur at the "preclinical" stage, i.e prior to the symptomatic onset of memory loss. In this session of Grand Rounds from the University of Arizona College of Medicine, participants learn about Alzheimer's Disease from an unique perspective...2011-04-1900 minGeriatricsGeriatricsUniversity of Arizona - Preclinical Stage Alzheimer's Disease: Characterizing and Defining the Transition Between Normal and Pathological Cognitive Aging, Part 2 Host: Matt Birnholz, MD For people who carry genetic predispositions toward Alzheimer's Disease, little is currently known about predicting the onset, course, and severity of disease at the individual level. However, because cogntitive degenerative diseases most often follow a gradual course of symptom progression later in life, medical professionals must be aware of the distinct, discoverable changes that occur at the "preclinical" stage, i.e prior to the symptomatic onset of memory loss. In this session of Grand Rounds from the University of Arizona College of Medicine, participants learn about Alzheimer's Disease from an unique perspective...2011-04-1900 minNeurology and NeurosurgeryNeurology and NeurosurgeryUniversity of Arizona - Preclinical Stage Alzheimer's Disease: Characterizing and Defining the Transition Between Normal and Pathological Cognitive Aging, Part 2 Host: Matt Birnholz, MD For people who carry genetic predispositions toward Alzheimer's Disease, little is currently known about predicting the onset, course, and severity of disease at the individual level. However, because cogntitive degenerative diseases most often follow a gradual course of symptom progression later in life, medical professionals must be aware of the distinct, discoverable changes that occur at the "preclinical" stage, i.e prior to the symptomatic onset of memory loss. In this session of Grand Rounds from the University of Arizona College of Medicine, participants learn about Alzheimer's Disease from an unique perspective...2011-04-1900 minNeurology and NeurosurgeryNeurology and NeurosurgeryUniversity of Arizona - Preclinical Stage Alzheimer's Disease: Characterizing and Defining the Transition Between Normal and Pathological Cognitive Aging, Part 2 Host: Matt Birnholz, MD For people who carry genetic predispositions toward Alzheimer's Disease, little is currently known about predicting the onset, course, and severity of disease at the individual level. However, because cogntitive degenerative diseases most often follow a gradual course of symptom progression later in life, medical professionals must be aware of the distinct, discoverable changes that occur at the "preclinical" stage, i.e prior to the symptomatic onset of memory loss. In this session of Grand Rounds from the University of Arizona College of Medicine, participants learn about Alzheimer's Disease from an unique perspective...2011-04-1900 minGrand Rounds NationGrand Rounds NationUniversity of Arizona - Preclinical Stage Alzheimer's Disease: Characterizing and Defining the Transition Between Normal and Pathological Cognitive Aging, Part 2Host: Matt Birnholz, MD For people who carry genetic predispositions toward Alzheimer's Disease, little is currently known about predicting the onset, course, and severity of disease at the individual level. However, because cogntitive degenerative diseases most often follow a gradual course of symptom progression later in life, medical professionals must be aware of the distinct, discoverable changes that occur at the "preclinical" stage, i.e prior to the symptomatic onset of memory loss. In this session of Grand Rounds from the University of Arizona College of Medicine, participants learn about Alzheimer's Disease from an unique perspective...2011-04-1900 minGeriatricsGeriatricsUniversity of Arizona - Preclinical Stage Alzheimer's Disease: Characterizing and Defining the Transition Between Normal and Pathological Cognitive Aging, Part 2 Host: Matt Birnholz, MD For people who carry genetic predispositions toward Alzheimer's Disease, little is currently known about predicting the onset, course, and severity of disease at the individual level. However, because cogntitive degenerative diseases most often follow a gradual course of symptom progression later in life, medical professionals must be aware of the distinct, discoverable changes that occur at the "preclinical" stage, i.e prior to the symptomatic onset of memory loss. In this session of Grand Rounds from the University of Arizona College of Medicine, participants learn about Alzheimer's Disease from an unique perspective...2011-04-1900 minNeurology and NeurosurgeryNeurology and NeurosurgeryUniversity of Arizona - Preclinical Stage Alzheimer's Disease: Characterizing and Defining the Transition Between Normal and Pathological Cognitive Aging, Part 1 Host: Matt Birnholz, MD For people who carry genetic predispositions toward Alzheimer's disease, little is currently known about predicting the onset, course, and severity of disease at the individual level. However, because cogntitive degenerative diseases most often follow a gradual course of symptom progression later in life, medical professionals must be aware of the distinct, discoverable changes that occur at the "preclinical" stage, i.e prior to the symptomatic onset of memory loss. In this session of Grand Rounds from the University of Arizona College of Medicine, participants learn about Alzheimer's Disease from a unique perspective...2011-04-1900 minGeriatricsGeriatricsUniversity of Arizona - Preclinical Stage Alzheimer's Disease: Characterizing and Defining the Transition Between Normal and Pathological Cognitive Aging, Part 1 Host: Matt Birnholz, MD For people who carry genetic predispositions toward Alzheimer's disease, little is currently known about predicting the onset, course, and severity of disease at the individual level. However, because cogntitive degenerative diseases most often follow a gradual course of symptom progression later in life, medical professionals must be aware of the distinct, discoverable changes that occur at the "preclinical" stage, i.e prior to the symptomatic onset of memory loss. In this session of Grand Rounds from the University of Arizona College of Medicine, participants learn about Alzheimer's Disease from a unique perspective...2011-04-1900 minGeriatricsGeriatricsUniversity of Arizona - Preclinical Stage Alzheimer's Disease: Characterizing and Defining the Transition Between Normal and Pathological Cognitive Aging, Part 1 Host: Matt Birnholz, MD For people who carry genetic predispositions toward Alzheimer's disease, little is currently known about predicting the onset, course, and severity of disease at the individual level. However, because cogntitive degenerative diseases most often follow a gradual course of symptom progression later in life, medical professionals must be aware of the distinct, discoverable changes that occur at the "preclinical" stage, i.e prior to the symptomatic onset of memory loss. In this session of Grand Rounds from the University of Arizona College of Medicine, participants learn about Alzheimer's Disease from a unique perspective...2011-04-1900 minNeurology and NeurosurgeryNeurology and NeurosurgeryUniversity of Arizona - Preclinical Stage Alzheimer's Disease: Characterizing and Defining the Transition Between Normal and Pathological Cognitive Aging, Part 1 Host: Matt Birnholz, MD For people who carry genetic predispositions toward Alzheimer's disease, little is currently known about predicting the onset, course, and severity of disease at the individual level. However, because cogntitive degenerative diseases most often follow a gradual course of symptom progression later in life, medical professionals must be aware of the distinct, discoverable changes that occur at the "preclinical" stage, i.e prior to the symptomatic onset of memory loss. In this session of Grand Rounds from the University of Arizona College of Medicine, participants learn about Alzheimer's Disease from a unique perspective...2011-04-1900 minGeneticsGeneticsUniversity of Arizona - Preclinical Stage Alzheimer's Disease: Characterizing and Defining the Transition Between Normal and Pathological Cognitive Aging, Part 1 Host: Matt Birnholz, MD For people who carry genetic predispositions toward Alzheimer's disease, little is currently known about predicting the onset, course, and severity of disease at the individual level. However, because cogntitive degenerative diseases most often follow a gradual course of symptom progression later in life, medical professionals must be aware of the distinct, discoverable changes that occur at the "preclinical" stage, i.e prior to the symptomatic onset of memory loss. In this session of Grand Rounds from the University of Arizona College of Medicine, participants learn about Alzheimer's Disease from a unique perspective...2011-04-1900 minGrand Rounds NationGrand Rounds NationUniversity of Arizona - Preclinical Stage Alzheimer's Disease: Characterizing and Defining the Transition Between Normal and Pathological Cognitive Aging, Part 1Host: Matt Birnholz, MD For people who carry genetic predispositions toward Alzheimer's disease, little is currently known about predicting the onset, course, and severity of disease at the individual level. However, because cogntitive degenerative diseases most often follow a gradual course of symptom progression later in life, medical professionals must be aware of the distinct, discoverable changes that occur at the "preclinical" stage, i.e prior to the symptomatic onset of memory loss. In this session of Grand Rounds from the University of Arizona College of Medicine, participants learn about Alzheimer's Disease from a unique perspective...2011-04-1900 minPublic HealthPublic HealthConference Coverage Highlights: Games for Health 2009 Host: Matt Birnholz, MD The fifth annual Games for Health Conference, held in Boston June 10-12, brought together several hundred people at the intersection of game development and health. The stated goal was to explore the use of game techology in health and healthcare and to discuss recent industry advancements. Those interviewed in this program include: Ben Sawyer, co-founder of the conference; Richard Tate of HopeLab; Jerry Heneghan of Virtual Heroes; Richard Levine, developer of the video game "Microsurgeon;" Stephen Downs of the Robert Wood Johnson Foundation; Paul Puopolo of Humana; and Steve Brown of 3banana.2009-06-1700 minConference CoverageConference CoverageConference Coverage Highlights: Games for Health 2009 Host: Matt Birnholz, MD The fifth annual Games for Health Conference, held in Boston June 10-12, brought together several hundred people at the intersection of game development and health. The stated goal was to explore the use of game techology in health and healthcare and to discuss recent industry advancements. Those interviewed in this program include: Ben Sawyer, co-founder of the conference; Richard Tate of HopeLab; Jerry Heneghan of Virtual Heroes; Richard Levine, developer of the video game "Microsurgeon;" Stephen Downs of the Robert Wood Johnson Foundation; Paul Puopolo of Humana; and Steve Brown of 3banana.2009-06-1700 minConference CoverageConference CoverageConference Coverage Highlights: Games for Health 2009 Host: Matt Birnholz, MD The fifth annual Games for Health Conference, held in Boston June 10-12, brought together several hundred people at the intersection of game development and health. The stated goal was to explore the use of game techology in health and healthcare and to discuss recent industry advancements. Those interviewed in this program include: Ben Sawyer, co-founder of the conference; Richard Tate of HopeLab; Jerry Heneghan of Virtual Heroes; Richard Levine, developer of the video game "Microsurgeon;" Stephen Downs of the Robert Wood Johnson Foundation; Paul Puopolo of Humana; and Steve Brown of 3banana.2009-06-1700 minTechnologyTechnologyConference Coverage Highlights: Games for Health 2009 Host: Matt Birnholz, MD The fifth annual Games for Health Conference, held in Boston June 10-12, brought together several hundred people at the intersection of game development and health. The stated goal was to explore the use of game techology in health and healthcare and to discuss recent industry advancements. Those interviewed in this program include: Ben Sawyer, co-founder of the conference; Richard Tate of HopeLab; Jerry Heneghan of Virtual Heroes; Richard Levine, developer of the video game "Microsurgeon;" Stephen Downs of the Robert Wood Johnson Foundation; Paul Puopolo of Humana; and Steve Brown of 3banana.2009-06-1700 minHospital MedicineHospital MedicineConference Coverage Highlights: Games for Health 2009 Host: Matt Birnholz, MD The fifth annual Games for Health Conference, held in Boston June 10-12, brought together several hundred people at the intersection of game development and health. The stated goal was to explore the use of game techology in health and healthcare and to discuss recent industry advancements. Those interviewed in this program include: Ben Sawyer, co-founder of the conference; Richard Tate of HopeLab; Jerry Heneghan of Virtual Heroes; Richard Levine, developer of the video game "Microsurgeon;" Stephen Downs of the Robert Wood Johnson Foundation; Paul Puopolo of Humana; and Steve Brown of 3banana.2009-06-1700 minCareersCareersConference Coverage Highlights: Games for Health 2009Host: Matt Birnholz, MD The fifth annual Games for Health Conference, held in Boston June 10-12, brought together several hundred people at the intersection of game development and health. The stated goal was to explore the use of game techology in health and healthcare and to discuss recent industry advancements. Those interviewed in this program include: Ben Sawyer, co-founder of the conference; Richard Tate of HopeLab; Jerry Heneghan of Virtual Heroes; Richard Levine, developer of the video game "Microsurgeon;" Stephen Downs of the Robert Wood Johnson Foundation; Paul Puopolo of Humana; and Steve...2009-06-1700 min